Dr. Jason Lickliter heads Nucleus Network’s Medical Department; this includes a multi-site team of Medical Officers. Jason has extensive experience across all aspects of early phase clinical trials from protocol design and implementation to the integration of Biomarker studies and advanced imaging into clinical research. With a Medical Oncology and Clinical Hematology background, his achievements include the establishment of a Phase 1 Cancer Trials Program at Monash Medical Centre.
Ann: Amplia Appoints Dr Jason Lickliter as Chief Medical Officer, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 23.5¢ | $951.7K | 3.939M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19377 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 152052 | 4 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |